AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28295451 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3050002 (5 mg kg-1 and higher)
Number of subjects: 48
Study 28295451 — intervention group
Group type: COMPARATOR
Intervention: GSK3050002
Number of subjects: 48
Study 25850127 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Integrative Puzzle (CIP)
Number of subjects: 36
Study 23802878 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention Group (BIG)
Number of subjects: 476
Study 23802878 — intervention group
Group type: COMPARATOR
Intervention: Contact Control Group (CCG)
Number of subjects: 476
Study 23802878 — intervention group
Group type: COMPARATOR
Intervention: No-Contact Control Group (NCG)
Number of subjects: 476
Study 21193422 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg of vitamin K(1)
Number of subjects: 400
Study 21193422 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 μg of vitamin K(1)
Number of subjects: 400
Study 21193422 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg of vitamin K(1)
Number of subjects: 400
Study 21193422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 19811532 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted state (15.9 +/- 0.3 h since supper)
Number of subjects: 20
Study 19811532 — intervention group
Group type: COMPARATOR
Intervention: Fed state (1.6 +/- 0.1 h since breakfast)
Number of subjects: 20
Study 17050012 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training (30 min cycling at 60-70% of peak oxygen consumption for 5 days/week for 6 months)
Number of subjects: 24
Study 17050012 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 24
Study 17050012 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 15022805 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg cholestyramine-bound diclofenac (2 x 1 capsule Voltaren resinate) daily for 14 days
Number of subjects: 245
Study 15022805 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg cholestyramine-bound diclofenac (1 x 1 capsule) daily for 14 days
Number of subjects: 245
Study 15022805 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 245
Study 15022805 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose (75 mg)
Number of subjects: 245
Study 11255384 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 84
Study 11255384 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline (target steady-state level, 75-125 ng/mL) (n = 27)
Number of subjects: 84
Study 11255384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline-lithium combination (target steady-state level, 0.5-0.9 mEq/L) (n = 28)
Number of subjects: 84
Study 9544650 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive mitomycin C (MMC)
Number of subjects: 49
Study 9544650 — intervention group
Group type: COMPARATOR
Intervention: No adjunctive mitomycin C (SGTP control)
Number of subjects: 49
Study 9544650 — intervention group
Group type: COMPARATOR
Intervention: Primary glaucoma triple procedure (PGTP)
Number of subjects: 49
Study 7531355 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 11
Study 7531355 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 11
Study 2582838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (400 micrograms, 600 micrograms, and 800 micrograms administered at 15-minute intervals, total dose 1.8 mg)
Number of subjects: 8
Study 2582838 — intervention group
Group type: COMPARATOR
Intervention: Theophylline alone
Number of subjects: 8
Study 2582838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 8
Study 825778 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine
Number of subjects: 0
Study 825778 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 0
Study 825778 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan
Number of subjects: 0
Study 31609667 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL + RF combination therapy
Number of subjects: 47
Study 31609667 — intervention group
Group type: COMPARATOR
Intervention: IPL
Number of subjects: 47
Study 31609667 — intervention group
Group type: COMPARATOR
Intervention: RF
Number of subjects: 47
Study 31476481 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg, 2 doses: 2 hours before and 24 hours after surgery)
Number of subjects: 80
Study 31476481 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 doses, 2 hours before and 24 hours after surgery)
Number of subjects: 80
Study 31476481 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 80
Study 31476481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 30379386 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention including brief advice, clinical consultation, and referral to a 6-month telephone-based coaching service
Number of subjects: 160
Study 30379386 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 160
Study 28834070 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN)
Number of subjects: 282
Study 28834070 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 282
Study 28834070 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Health Care Costs
Number of subjects: 282
Study 28834070 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Care Physician (PCP) Visits
Number of subjects: 282
Study 26056920 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-containing group (35 cases)
Number of subjects: 148
Study 26056920 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (37 cases)
Number of subjects: 148
Study 23527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-AMED group
Number of subjects: 387
Study 23527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Occasional AMED group
Number of subjects: 387
Study 23527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-AMED group
Number of subjects: 387
Study 23527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong peer influence group
Number of subjects: 387
Study 23527941 — intervention group
Group type: EXPERIMENTAL
Intervention: AMED-specific messages in brief interventions
Number of subjects: 387
Study 20543765 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR)
Number of subjects: 454
Study 20543765 — intervention group
Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 454
Study 19967902 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention
Number of subjects: 107
Study 19967902 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-efficacy
Number of subjects: 107
Study 17105693 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic arnica (1 x 5 globules of dilution 30x before surgery and 3 x 5 globules daily after surgery)
Number of subjects: 319
Study 17105693 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 x 5 globules before surgery and 3 x 5 globules daily after surgery)
Number of subjects: 319
Study 15612850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Management Class (LMC)
Number of subjects: 0
Study 11534876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 32
Study 11534876 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 32
Study 11534876 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 32
Study 9403152 — intervention group
Group type: EXPERIMENTAL
Intervention: Cambridge Contextual Reading Test (CCRT)
Number of subjects: 0
Study 9403152 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot‐the‐Word Test
Number of subjects: 0
Study 9403152 — intervention group
Group type: COMPARATOR
Intervention: National Adult Reading Test (NART)
Number of subjects: 0
Study 8240617 — intervention group
Group type: EXPERIMENTAL
Intervention: Term Guard monitoring system
Number of subjects: 0
Study 8240617 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 3554095 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency neural modulation
Number of subjects: 0
Study 3554095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31991636 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely Randomized Trees algorithm with IMU sensor data sampled at 50 Hz and 5-s windows
Number of subjects: 0
Study 31991636 — intervention group
Group type: COMPARATOR
Intervention: Baseline of smartphone non-use while sitting and walking
Number of subjects: 0
Study 29440881 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk orthosis with joints providing resistive force (TORF)
Number of subjects: 28
Study 29440881 — intervention group
Group type: COMPARATOR
Intervention: Corset (control group)
Number of subjects: 28
Study 26350603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal pressure (NP)
Number of subjects: 15
Study 26350603 — intervention group
Group type: EXPERIMENTAL
Intervention: Transformed nasal pressure (transformed NP)
Number of subjects: 15
Study 26350603 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory inductive plethysmography (RIP) flow
Number of subjects: 15
Study 24346102 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg LY293111
Number of subjects: 200
Study 24346102 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg LY293111
Number of subjects: 200
Study 24346102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 23736006 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (diet M)
Number of subjects: 260
Study 23736006 — intervention group
Group type: COMPARATOR
Intervention: High polyunsaturated fat hypocaloric diet (diet P)
Number of subjects: 260
Study 20733212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hoped-for possible selves intervention
Number of subjects: 80
Study 20733212 — intervention group
Group type: EXPERIMENTAL
Intervention: Feared possible selves intervention
Number of subjects: 80
Study 20733212 — intervention group
Group type: COMPARATOR
Intervention: Control condition (quiz about physical activity)
Number of subjects: 80
Study 18506165 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 0
Study 18506165 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 18506165 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab alongside chemotherapy
Number of subjects: 0
Study 15890169 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to interpret emotionally ambiguous passages in a negative direction
Number of subjects: 0
Study 15890169 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to interpret emotionally ambiguous passages in a positive direction
Number of subjects: 0
Study 15890169 — intervention group
Group type: EXPERIMENTAL
Intervention: Training effects over time spans of up to 1 day
Number of subjects: 0
Study 12814281 — intervention group
Group type: EXPERIMENTAL
Intervention: Social/sexual expectancy‐challenge intervention
Number of subjects: 46
Study 12814281 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 46
Study 11027880 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton magnetic resonance spectroscopy (MRS)
Number of subjects: 30
Study 11027880 — intervention group
Group type: COMPARATOR
Intervention: Control group (13 controls)
Number of subjects: 30
Study 9119942 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face communication task
Number of subjects: 0
Study 9119942 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-only communication task
Number of subjects: 0
Study 1639583 — intervention group
Group type: EXPERIMENTAL
Intervention: Condress (patented sheets of pure bovine collagen)
Number of subjects: 45
Study 6748071 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG training on the forehead (frontal area)
Number of subjects: 32
Study 6748071 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG training on the frontal area, neck (sternomastoid), and forearm areas in succession
Number of subjects: 32
Study 6748071 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG training with relaxation instructions used at home
Number of subjects: 32
Study 6748071 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 32
Study 6748071 — intervention group
Group type: EXPERIMENTAL
Intervention: Other measures (peripheral temperatures and self-reported anxiety)
Number of subjects: 32
Study 31126419 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study 31126419 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 29385147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols (up to 113.4 mg THC/105 mg CBD)
Number of subjects: 40
Study 29385147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29385147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 40
Study 27130175 — intervention group
Group type: EXPERIMENTAL
Intervention: Core strategy for promoting change
Number of subjects: 36
Study 27130175 — intervention group
Group type: COMPARATOR
Intervention: Enhanced strategy (Core + active facilitation)
Number of subjects: 36
Study 24634423 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily bathing instructions
Number of subjects: 28
Study 24634423 — intervention group
Group type: COMPARATOR
Intervention: Twice a week bathing instructions
Number of subjects: 28
Study 22221014 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 71
Study 22221014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 20585106 — intervention group
Group type: EXPERIMENTAL
Intervention: Modest reduction in salt intake from 9.7 to 6.5 g/day
Number of subjects: 169
Study 17435354 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest area group (6 subjects)
Number of subjects: 12
Study 17435354 — intervention group
Group type: COMPARATOR
Intervention: City area group (6 subjects)
Number of subjects: 12
Study 16822124 — intervention group
Group type: EXPERIMENTAL
Intervention: Pairs of visual stimuli (626-nm LEDs) with 13 stimulus onset asynchronies
Number of subjects: 0
Study 12797717 — intervention group
Group type: EXPERIMENTAL
Intervention: English version completed first, followed by Chinese version (same occasion)
Number of subjects: 309
Study 12797717 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese version completed first, followed by English version (same occasion)
Number of subjects: 309
Study 12797717 — intervention group
Group type: EXPERIMENTAL
Intervention: English version completed once and then again 1-week later
Number of subjects: 309
Study 12797717 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese version completed once and then again 1-week later
Number of subjects: 309
Study 12797717 — intervention group
Group type: COMPARATOR
Intervention: Both versions of the SF-36
Number of subjects: 309
Study 10821362 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose L-folinic acid (175 mg)
Number of subjects: 4927
Study 10821362 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose L-folinic acid (25 mg)
Number of subjects: 4927
Study 10821362 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (50 mg)
Number of subjects: 4927
Study 10821362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4927
Study 8669651 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine by subcutaneous infusion (0.1 mg/kg/h)
Number of subjects: 40
Study 8669651 — intervention group
Group type: COMPARATOR
Intervention: Intermittent morphine (0.1 mg/kg intravenously, four‐hourly)
Number of subjects: 40
Study 1900254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU of alpha-interferon given three times a week for 24 weeks
Number of subjects: 60
Study 1900254 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MU of alpha-interferon given three times a week for 24 weeks
Number of subjects: 60
Study 1900254 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study 6341478 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicella-zoster immune globulin (VZIG)
Number of subjects: 164
Study 6341478 — intervention group
Group type: COMPARATOR
Intervention: Zoster immune globulin (ZIG)
Number of subjects: 164
Study 31812149 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962 (sustained-release nimodipine) - 100-1200 mg as a single intraventricular injection
Number of subjects: 72
Study 31812149 — intervention group
Group type: COMPARATOR
Intervention: Oral nimodipine
Number of subjects: 72
Study 27597563 — intervention group
Group type: EXPERIMENTAL
Intervention: Early infant circumcision (EIC) performed by clinical officers (COs)
Number of subjects: 501
Study 27597563 — intervention group
Group type: EXPERIMENTAL
Intervention: Early infant circumcision (EIC) performed by registered nurse midwives (RNMWs)
Number of subjects: 501
Study 25894914 — intervention group
Group type: EXPERIMENTAL
Intervention: TruView video laryngoscope
Number of subjects: 120
Study 25894914 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 120
Study 23350795 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine, final mean dosage 0.44 units/kg, treatment duration 6 months
Number of subjects: 2251
Study 23350795 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 2251
Study 20628767 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Specific Functional Scale (PSFS)
Number of subjects: 831
Study 20628767 — intervention group
Group type: COMPARATOR
Intervention: Roland Morris Disability Questionnaire (RMDQ)
Number of subjects: 831
Study 19678812 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bisacodyl (5 mg p.o. per day)
Number of subjects: 25
Study 19678812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 17432642 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved acupoints and rehabilitation exercise (Group A)
Number of subjects: 578
Study 17432642 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation exercise (Group B)
Number of subjects: 578
Study 17432642 — intervention group
Group type: COMPARATOR
Intervention: Routine acupoints and rehabilitation exercise (Group C)
Number of subjects: 578
Study 17432642 — intervention group
Group type: COMPARATOR
Intervention: Medication (Group D)
Number of subjects: 578
Study 15589083 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported pain by persons with dementia
Number of subjects: 0
Study 15589083 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver reports of pain in care recipients with dementia
Number of subjects: 0
Study 15589083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic congruence of pain reports
Number of subjects: 0
Study 15589083 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors predicting congruence of pain reports
Number of subjects: 0
Study 11569692 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg twice daily
Number of subjects: 801
Study 9211136 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program (video and brochures)
Number of subjects: 0
Study 9211136 — intervention group
Group type: COMPARATOR
Intervention: Unexposed group (no education program)
Number of subjects: 0
Study 8181022 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention to prevent heart failure and progression of cardiac dysfunction
Number of subjects: 0
Study 3325259 — intervention group
Group type: EXPERIMENTAL
Intervention: ofloxacin 800 mg once daily for 7 days
Number of subjects: 271
Study 3325259 — intervention group
Group type: EXPERIMENTAL
Intervention: enoxacin
Number of subjects: 271
Study 3325259 — intervention group
Group type: EXPERIMENTAL
Intervention: pefloxacin
Number of subjects: 271
Study 3325259 — intervention group
Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Number of subjects: 271
Study 3325259 — intervention group
Group type: EXPERIMENTAL
Intervention: various new oral quinolones
Number of subjects: 271
Study 29338540 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CAP (bortezomib)
Number of subjects: 80
Study 29338540 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP (vincristine)
Number of subjects: 80
Study 29338540 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CAP
Number of subjects: 80
Study 29338540 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 80
Study 27023594 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% of calories from high fructose corn syrup (HFCS)
Number of subjects: 267
Study 27023594 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% of calories from sucrose
Number of subjects: 267
Study 27023594 — intervention group
Group type: EXPERIMENTAL
Intervention: 9% of calories from fructose
Number of subjects: 267
Study 27023594 — intervention group
Group type: EXPERIMENTAL
Intervention: 9% of calories from glucose
Number of subjects: 267
Study 23958035 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT (Community Restitution Apprenticeship‐Focused Training)
Number of subjects: 97
Study 23958035 — intervention group
Group type: COMPARATOR
Intervention: Education as Usual (EAU)
Number of subjects: 97
Study 23958035 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT
Number of subjects: 97
Study 23457685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful attention
Number of subjects: 82
Study 23457685 — intervention group
Group type: COMPARATOR
Intervention: Guided imagery
Number of subjects: 82
Study 19901102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg twice daily
Number of subjects: 163
Study 19901102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg twice daily
Number of subjects: 163
Study 19901102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 18436904 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-triggered decision support
Number of subjects: 3449
Study 18436904 — intervention group
Group type: COMPARATOR
Intervention: On-demand drug review
Number of subjects: 3449
Study 16571160 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified sham feeding (MSF) with olive oil
Number of subjects: 36